New discovery could uncover 'missing link' in genetics
2/14/2014
Researchers believe that susceptibility to common diseases stems from a combination of common genetic variants and a variety of rare genetic mutations. But this only accounts for a small proportion of potential heritable risk factors for disease.
Increased blood clot risk in women for at least 12 weeks after birth
2/14/2014
According to the Centers for Disease Control and Prevention, women have an increased risk of blood clots for up to 6 weeks after giving birth. But new research suggests that the risk of a blood clot remains higher than normal for a minimum of 12 weeks after delivering a baby.The research team, led by Dr.
New discovery could uncover 'missing link' in genetics
2/14/2014
Researchers believe that susceptibility to common diseases stems from a combination of common genetic variants and a variety of rare genetic mutations. But this only accounts for a small proportion of potential heritable risk factors for disease.
Increased blood clot risk in women for at least 12 weeks after birth
2/14/2014
According to the Centers for Disease Control and Prevention, women have an increased risk of blood clots for up to 6 weeks after giving birth. But new research suggests that the risk of a blood clot remains higher than normal for a minimum of 12 weeks after delivering a baby.The research team, led by Dr.
High-tech glasses help surgeons see cancer cells
2/13/2014
Researchers at Washington University School of Medicine in St. Louis, MO, have developed a way of visualizing cancer cells using high-tech glasses designed to make it easier for surgeons to distinguish between cancerous and healthy tissue.
Prostate cancer advance could improve treatment options
2/13/2014
Researchers at the University of East Anglia have made an important advance in understanding genetic changes associated with terminal prostate cancer.Findings published today in the British Journal of Cancer, and funded by the Association for International Cancer Research (AICR), show how a genetic mutation in untreated patients is linked to aggressive cancer later in life.
Five years after having proton therapy for early- and intermediate-risk prostate cancer, 99 percent of men are living cancer-free and with excellent quality of life, according to a University of Florida Proton Therapy Institute study. Three-quarters of those with high-risk prostate cancer are also disease-free.
New breast cancer treatment Kadcyla given green light by regulators, UK
2/13/2014
Kadcyla is now available for patients with advanced HER2-positive breast cancer. Kadcyla is the first medicine of its kind in breast cancer, consisting of the HER2-targeted antibody, trastuzumab (contained in the medicine Herceptin), linked with the chemotherapy agent, DM1.
Schizophrenia enters the molecular diagnostics era
2/13/2014
With a drop of blood and some laboratory analyses, doctors have been able to tell patients whether they suffer from diabetes or some sort of cancer. Measuring changes in the cells or molecules of human tissues or fluids, by detecting so-called biomarkers, has aided the diagnosis of various diseases for some time.
Prostate cancer advance could improve treatment options
2/13/2014
Researchers at the University of East Anglia have made an important advance in understanding genetic changes associated with terminal prostate cancer.Findings published today in the British Journal of Cancer, and funded by the Association for International Cancer Research (AICR), show how a genetic mutation in untreated patients is linked to aggressive cancer later in life.